Cannabinoids affect dendritic cell (DC) potassium channel function and modulate DC T cell stimulatory capacity

Journal of Immunology

Volumn 181, Issue 5, 2008, Pages 3057-3066

  Wacnik, Paul W ^a,b   Luhr, Katarina M ^a   Hill, Russell H ^a   Ljunggren, Hans Gustaf ^b   Kristensson, Krister ^a   Svensson, Mattias ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; CALCIUM CHANNEL; POTASSIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; CANNABINOID; CANNABINOID 1 RECEPTOR; HLA ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; MOUSE; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG EFFECT; ELECTROPHYSIOLOGY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; CALCIUM CHANNELS; CANNABINOIDS; DENDRITIC CELLS; ELECTROPHYSIOLOGY; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTOR, CANNABINOID, CB1; T-LYMPHOCYTES;

EID: 51549090440     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.5.3057     Document Type: Article

References (63)

1. Piomelli, D. 2003. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4: 873-884.
2. 2 receptor-mediated signalling: a focus on endocannabinoids. Prostaglandins Leukot. Essent. Fatty Acids 66: 161-171.
3. Pertwee, R. G., and R. A. Ross. 2002. Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids 66: 101-121.
4. Howlett, A. C., F. Barth, T. I. Bonner, G. Cabral, P. Casellas, W. A. Devane, C. C. Felder, M. Herkenham, K. Mackie, B. R. Martin, et al. 2002. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54: 161-202. (Pubitemid 34575709)
5. Blednov, Y. A., M. Stoffel, H. Alva, and R. A. Harris. 2003. A pervasive mechanism for analgesia: activation of GIRK2 channels. Proc. Natl. Acad. Sci. USA 100: 277-282.
6. Guo, J., and S. R. Ikeda. 2004. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol. Pharmacol. 65: 665-674. (Pubitemid 38264034)
7. Khasabova, I. A., C. Harding-Rose, D. A. Simone, and V. S. Seybold. 2004. Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. J. Neurosci. 24: 1744-1753.
8. + M-current in hippocampal CA1 neurons. J. Neurosci. 20: 51-58.
9. Twitchell, W., S. Brown, and K. Mackie. 1997. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78: 43-50. (Pubitemid 27318909)
10. Klein, T. W. 2005. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 5: 400-411.
11. Arevalo-Martin, A., J. M. Vela, E. Molina-Holgado, J. Borrell, and C. Guaza. 2003. Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J. Neurosci. 23: 2511-2516. (Pubitemid 36418583)
12. Croxford, J. L., and S. D. Miller. 2003. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212. J. Clin. Invest. 111: 1231-1240.
13. + currents of mouse dendritic cells. FEBS Lett. 373: 127-130.
14. + channels as targets for specific immunomodulation. Trends Pharmacol. Sci. 25: 280-289.
15. Panyi, G., R. Gaspar, Z. Krasznai, J. J. ter Horst, M. Ameloot, A. Aszalos, P. Steels, and S. Damjanovich. 1996. Immunosuppressors inhibit voltage-gated potassium channels in human peripheral blood lymphocytes. Biochem. Biophys. Res. Commun. 221: 254-258.
16. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
17. Reis e Sousa, C. 2006. Dendritic cells in a mature age. Nat. Rev. Immunol. 6: 476-483.
18. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388: 782-787. (Pubitemid 27375158)
19. Pierre, P., S. J. Turley, E. Gatti, M. Hull, J. Meltzer, A. Mirza, K. Inaba, R. M. Steinman, and I. Mellman. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388: 787-792. (Pubitemid 27375159)
20. Shin, J. S., M. Ebersold, M. Pypaert, L. Delamarre, A. Hartley, and I. Mellman. 2006. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444: 115-118.
21. Turley, S. J., K. Inaba, W. S. Garrett, M. Ebersold, J. Unternaehrer, R. M. Steinman, and I. Mellman. 2000. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288: 522-527.
22. Wilson, N. S., D. El-Sukkari, and J. A. Villadangos. 2004. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103: 2187-2195.
23. Inaba, K., M. Witmer-Pack, M. Inaba, K. S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P. S. Linsley, S. Ikehara, et al. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180: 1849-1860. (Pubitemid 24328575)
24. Larsen, C. P., S. C. Ritchie, T. C. Pearson, P. S. Linsley, and R. P. Lowry. 1992. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J. Exp. Med. 176: 1215-1220.
25. Reis e Sousa, C., S. Hieny, T. Scharton-Kersten, D. Jankovic, H. Charest, R. N. Germain, and A. Sher. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186: 1819-1829.
26. Whelan, M., M. M. Harnett, K. M. Houston, V. Patel, W. Harnett, and K. P. Rigley. 2000. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J. Immunol. 164: 6453-6460. (Pubitemid 30408828)
27. Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993.
28. Hackstein, H., and A. W. Thomson. 2004. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4: 24-34. (Pubitemid 38084129)
29. Cahalan, M. D., and K. G. Chandy. 1997. Ion channels in the immune system as targets for immunosuppression. Curr. Opin. Biotechnol. 8: 749-756. (Pubitemid 27517253)
30. Hajas, G., E. Zsiros, T. Laszlo, P. Hajdu, S. Somodi, B. Rethi, P. Gogolak, K. Ludanyi, G. Panyi, and E. Rajnavolgyi. 2004. New phenotypic, functional and electrophysiological characteristics of KG-1 cells. Immunol. Lett. 92: 97-106. (Pubitemid 38470056)
31. 2+ entry pathway. J. Immunol. 166: 6126-6133.
32. Liu, Q. H., H. Bohlen, S. Titzer, O. Christensen, V. Diehl, J. Hescheler, and B. K. Fleischmann. 1999. Expression and a role of functionally coupled P2Y receptors in human dendritic cells. FEBS Lett. 445: 402-408.
33. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
34. + myeloid dendritic cells in vitro. J. Virol. 76: 12259-12264.
35. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391: 85-100.
36. Mukhopadhyay, S., and A. C. Howlett. 2001. CB1 receptor-G protein association: subtype selectivity is determined by distinct intracellular domains. Eur. J. Biochem. 268: 499-505. (Pubitemid 32862606)
37. Di Marzo, V., L. De Petrocellis, F. Fezza, A. Ligresti, and T. Bisogno. 2002. Anandamide receptors. Prostaglandins Leukot. Essent. Fatty Acids 66: 377-391.
38. + channels. Neuropharmacology 35: 983-991.
39. Ross, R. A. 2003. Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol. 140: 790-801.
40. Sancho, R., M. A. Calzado, V. Di Marzo, G. Appendino, and E. Munoz. 2003. Anandamide inhibits nuclear factor-κB activation through a cannabinoid receptor-independent pathway. Mol. Pharmacol. 63: 429-438. (Pubitemid 36158379)
41. Howlett, A. C., C. S. Breivogel, S. R. Childers, S. A. Deadwyler, R. E. Hampson, and L. J. Porrino. 2004. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47(Suppl. 1): 345-358. (Pubitemid 39298276)
42. Mullen, K. M., M. Rozycka, H. Rus, L. Hu, C. Cudrici, E. Zafranskaia, M. W. Pennington, D. C. Johns, S. I. Judge, and P. A. Calabresi. 2006. Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system. Ann. Neurol. 60: 118-127.
43. Cahalan, M. D., H. Wulff, and K. G. Chandy. 2001. Molecular properties and physiological roles of ion channels in the immune system. J. Clin. Immunol. 21: 235-252.
44. Matsuda, L. A., S. J. Lolait, M. J. Brownstein, A. C. Young, and T. I. Bonner. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564. (Pubitemid 20238806)
45. Munro, S., K. L. Thomas, and M. Abu-Shaar. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65. (Pubitemid 23305569)
46. De Petrocellis, L., M. G. Cascio, and V. Di Marzo. 2004. The endocannabinoid system: a general view and latest additions. Br. J. Pharmacol. 141: 765-774. (Pubitemid 38446177)
47. Klein, T. W., C. Newton, K. Larsen, L. Lu, I. Perkins, L. Nong, and H. Friedman. 2003. The cannabinoid system and immune modulation. J. Leukocyte Biol. 74: 486-496.
48. Matias, I., P. Pochard, P. Orlando, M. Salzet, J. Pestel, and V. Di Marzo. 2002. Presence and regulation of the endocannabinoid system in human dendritic cells. Eur. J. Biochem. 269: 3771-3778. (Pubitemid 34989126)
49. Do, Y., R. J. McKallip, M. Nagarkatti, and P. S. Nagarkatti. 2004. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-κB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. J. Immunol. 173: 2373-2382. (Pubitemid 39063093)
50. Conforti, L., M. Petrovic, D. Mohammad, S. Lee, Q. Ma, S. Barone, and A. H. Filipovich. 2003. Hypoxia regulates expression and activity of Kv1.3 channels in T lymphocytes: a possible role in T cell proliferation. J. Immunol. 170: 695-702. (Pubitemid 36070518)
51. Shah, K., J. Tom Blake, C. Huang, P. Fischer, and G. C. Koo. 2003. Immunosuppressive effects of a Kv1.3 inhibitor. Cell Immunol. 221: 100-106.
52. Eljaschewitsch, E., A. Witting, C. Mawrin, T. Lee, P. M. Schmidt, S. Wolf, H. Hoertnagl, C. S. Raine, R. Schneider-Stock, R. Nitsch, and O. Ullrich. 2006. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49: 67-79. (Pubitemid 43017186)
53. Lambrecht, B. N. 2001. Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir. Res. 2: 133-138. (Pubitemid 34187918)
54. Luger, T. A. 2002. Neuromediators: a crucial component of the skin immune system. J. Dermatol. Sci. 30: 87-93.
55. Downing, J. E., and J. A. Miyan. 2000. Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol. Today 21: 281-289.
56. Tournier, J. N., and A. Q. Hellmann. 2003. Neuro-immune connections: evidence for a neuro-immunological synapse. Trends Immunol. 24: 114-115.
57. Langerhans, P. 1868. Über die nerven der menschlichen haut. Virchows Arch. Pathol. Anat. Physiol. 44: 325-337.
58. Egan, C. L., M. J. Viglione-Schneck, L. J. Walsh, B. Green, J. Q. Trojanowski, D. Whitaker-Menezes, and G. F. Murphy. 1998. Characterization of unmyelinated axons uniting epidermal and dermal immune cells in primate and murine skin. J. Cutan. Pathol. 25: 20-29.
59. Gaudillere, A., L. Misery, C. Souchier, A. Claudy, and D. Schmitt. 1996. Intimate associations between PGP9.5-positive nerve fibres and Langerhans cells. Br. J. Dermatol. 135: 343-344. (Pubitemid 26253008)
60. Hosoi, J., G. F. Murphy, C. L. Egan, E. A. Lerner, S. Grabbe, A. Asahina, and R. D. Granstein. 1993. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363: 159-163. (Pubitemid 23147013)
61. Muller, T. 2000. Intraepidermal free nerve fiber endings in the hairless skin of the rat as revealed by the zinc iodide-osmium tetroxide technique. Histol. Histopathol. 15: 493-498. (Pubitemid 30218845)
62. Markus, A. M., F. Kockerling, and W. L. Neuhuber. 1998. Close anatomical relationships between nerve fibers and MHC class II-expressing dendritic cells in the rat liver and extrahepatic bile duct. Histochem. Cell Biol. 109: 409-415.
63. Ahluwalia, J., M. Yaqoob, L. Urban, S. Bevan, and I. Nagy. 2003. Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J. Neurochem. 84: 585-591. (Pubitemid 36182257)